R-Pharm International, LLC

Quick facts

Phase 3 pipeline

• Concomitant treatment
  Concomitant treatment refers to the simultaneous administration of multiple therapeutic agents to enhance efficacy or address multiple disease pathways.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• R-Pharm International, LLC portfolio CI brief
• R-Pharm International, LLC pipeline updates RSS